KrabbeConnect, Hunter's Hope Foundation, and The United Leukodystrophy Foundation present this survey in partnership with the sponsor Neurogene. |
Purpose: To understand general perceptions of KD, clinical trials, and potential treatments
This survey is being sponsored by Neurogene and supported by KrabbeConnect, Hunters Hope Foundation, and The United Leukodystrophy Foundation. Neurogene is a biotech company focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.